<?xml version='1.0' encoding='utf-8'?>
<document id="30445219"><sentence text="Manifold regularized matrix factorization for drug-drug interaction prediction." /><sentence text="Drug-drug interaction (DDI) prediction is one of the most important tasks in drug discovery" /><sentence text=" Prediction of potential DDIs helps to reduce unexpected side effects in the lifecycle of drugs, and is important for the drug safety surveillance"><entity charOffset="77-86" id="DDI-PubMed.30445219.s3.e0" text="lifecycle" /></sentence><sentence text=" Here, we formulate the drug-drug interaction prediction as a matrix completion task, and project drugs in the interaction space into a low-dimensional space" /><sentence text=" We consider drug features, i" /><sentence text="e" /><sentence text=", substructures, targets, enzymes, transporters, pathways, indications, side effects, and off side effects, to calculate drug-drug similarities, and assume them as manifolds in feature spaces" /><sentence text=" In this paper, we present a novel computational method named &quot;Manifold Regularized Matrix Factorization&quot; (MRMF) to predict potential drug-drug interactions, by introducing the drug feature-based manifold regularization into the matrix factorization" /><sentence text=" In the computational experiments, the MRMF models, which utilize known drug-drug interactions and the drug feature-based manifold, produce the area under precision-recall curves (AUPR) up to 0" /><sentence text="7963" /><sentence text=" We test manifold regularizations based on different drug features, and the MRMF models can produce robust performances" /><sentence text=" Compared with other state-of-the-art methods, the MRMF models can produce better performances in the cross validation and case study" /><sentence text=" The manifold regularization is the critical factor for the high-accuracy performances of our method" /><sentence text=" MRMF is promising and effective for the prediction of drug-drug interactions" /><sentence text="" /></document>